This study investigated how providing hay mixed with calf starter to dairy calves affected their solid feed intake, feed sorting, growth, and plasma metabolite and hormone concentrations. Forty Holstein heifer calves were fed a texturized calf starter (23.4% crude protein, 32.3% starch on a dry matter basis) and chopped Klein grass hay as separate components (CONT) or the same starter and hay mixed at a 90:10 ratio on an as-fed basis (MIX) ad libitum from the date transported to the research farm (4-7 d of life) to 90 d of life. Calves were provided milk replacer (28% crude protein, 15% fat) at up to 557 g/d before the study, 737 g/d from d 14 to 20, 1,105 g/d from d 21 to 41, 737 g/d from d 42 to 48, and 557 g/d from d 49 to 55 on a dry matter basis. calves were fully weaned on d 56. Feed sorting for the MIX calves was evaluated using the Penn State Particle Separator; the sorting index was calculated as the actual intake as a percentage of predicted intake, with values >100% indicating sorting for and values <100% indicating sorting against. Treatment did not affect solid feed intake, growth performance, or plasma metabolite or hormone concentration during the preweaning or weaning periods. However, calves in the MIX treatment had less neutral detergent fiber intake as a percentage of solid feed intake than CONT calves in the preweaning (23.3 vs. 37.0%) and weaning (23.5 vs. 25.8%) periods, although MIX calves sorted (107.2%) for long particles, which were primarily hay, during weaning. During the postweaning period, MIX calves had greater neutral detergent fiber intake as a percentage of solid feed intake compared with CONT calves (23.4 vs. 22.7%), although they sorted against long particles (84.4%), and decreased solid feed dry matter intake compared with CONT calves (3,292 vs. 3,536 g/d) and average daily gain (1.20 vs. 1.31 kg/d). Weaned calves in the MIX treatment also had lower plasma concentration of glucagon-like peptide 2 compared with CONT (0.46 vs. 0.77 ng/mg) but had higher plasma concentrations of ghrelin (0.05 vs. 0.03 ng/mg). These results suggest that feeding a mixture of texturized calf starter and chopped hay at the 90:10 ratio to postweaned calves may decrease solid feed intake and growth.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Dairy cattle experience inflammation during the calving transition period, and butyrate and nonsteroidal anti-inflammatory drugs (NSAID) are expected to reduce the inflammation. Our objective was to evaluate the effects of dietary butyrate supplementation and oral NSAID administration on feed intake, serum inflammatory markers, plasma metabolites, and milk production of dairy cows during the calving transition period. Eighty-three Holstein cows were used in the experiment with a 2 × 2 factorial arrangement of treatments. The cows were blocked by parity and calving date, and randomly assigned to a dietary butyrate or control supplement, and NSAID or a placebo oral administration. Experimental diets were iso-energetic containing calcium butyrate at 1.42% of diet dry matter (DM) or the control supplement (1.04% commercial fat supplement and 0.38% calcium carbonate of diet DM). The close-up diets contained 13.3% starch and 42.4% neutral detergent fiber on a DM basis, and were fed from 28 d before expected calving date until calving. The postpartum diets contained 22.1% starch and 34.1% neutral detergent fiber on a DM basis and were fed from calving to 24 d after calving. Oral NSAID (1 mg of meloxicam/kg of body weight) or placebo (food dye) was administered 12 to 24 h after calving. Dietary butyrate supplementation and oral NSAID administration did not affect milk yield or postpartum serum concentrations of amyloid A and haptoglobin. However, butyrate-fed cows increased plasma fatty acid concentration on d −4 relative to calving (501 vs. 340 μEq/L) and tended to increase serum haptoglobin concentration (0.23 vs. 0.10 mg/mL). There was a supplement by drug interaction effect on plasma glucose concentration on d 4; in cows administered the placebo drug, butyrate supplementation decreased plasma glucose concentration compared with control-fed cows (62.8 vs. 70.1 mg/ dL). Butyrate-fed cows tended to have lower milk crude protein yield compared with cows fed the control diet (1.21 vs. 1.27 kg/d). Dietary butyrate supplementation and oral NSAID administration did not have overall positive effects on production performance of dairy cows during the calving transition period.

No abstract